Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, it confers a poorer prognosis. Catheter-based repair therapies face some …

Use of transcatheter mitral valve replacement (TMVR) using transcatheter aortic valves in
clinical practice is limited to patients with failing bioprostheses and rings or mitral valve …

With the advent of transcatheter mitral valve replacement (TMVR), the concept of the neo–
left ventricular outflow tract (LVOT) was introduced and remains an essential component of …

Aims Transcatheter mitral valve implantation (TMVI) is a new treatment option for patients
with symptomatic mitral valve (MV) disease. Real‐world data have not yet been reported …

Objectives The aim of this study was to evaluate 1-year outcomes of valve–in–mitral annular
calcification (ViMAC) in the MITRAL (Mitral Implantation of Transcatheter Valves) trial …

Minimally invasive strategies to treat valvular heart disease have emerged over the past 2
decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic …

Magnetic materials in tissue, such as iron, calcium, or collagen, can be studied using
quantitative susceptibility mapping (QSM). To date, QSM has been overwhelmingly applied …

Objectives The authors report 1-year outcomes of high-risk patients with failed surgical
annuloplasty rings undergoing transseptal mitral valve–in–ring (MViR) with the SAPIEN 3 …

Mitral annular calcification (MAC) is a common and challenging pathologic condition,
especially in the context of an aging society. Surgical mitral valve intervention in patients …

Mitral annular calcification (MAC) is a common clinical finding and is associated with
adverse clinical outcomes, but the clinical impact of MAC-related mitral valve (MV) …